This set of proteins, all of which were upregulated in the at-risk group, may represent a set of biological processes and molecular functions that ultimately determine the extent to which cognition can be preserved in the face of enhanced APOE-determined risk for AD and, as suggested by our results, VaD. Here, APOE is linked to Alzheimer disease.